Variant report

Variant	esv3370465
Chromosome Location	chr21:45168624-45172822
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr21:45170294-45171049	GM12878	blood:	n/a	n/a
2	BCL3	chr21:45169866-45170231	GM12878	blood:	n/a	n/a
3	BCL3	chr21:45170416-45171010	GM12878	blood:	n/a	n/a
4	CEBPB	chr21:45171588-45171771	HepG2	liver:	n/a	n/a
5	CEBPB	chr21:45171621-45171821	A549	lung:	n/a	n/a
6	CTCF	chr21:45169728-45169804	GM19238	blood:	n/a	chr21:45169768-45169781
7	CTCF	chr21:45170632-45170747	GM19239	blood:	n/a	n/a
8	CTCF	chr21:45169732-45169803	GM19240	blood:	n/a	chr21:45169768-45169781
9	CTCF	chr21:45169721-45169781	GM12892	blood:	n/a	chr21:45169768-45169781
10	CTCF	chr21:45169713-45169808	GM19239	blood:	n/a	chr21:45169768-45169781
11	CTCF	chr21:45169739-45169817	GM12891	blood:	n/a	chr21:45169768-45169781
12	CTCF	chr21:45169720-45169870	GM12878	blood:	n/a	chr21:45169768-45169781
13	CTCF	chr21:45169880-45170030	SAEC	small airway:	n/a	n/a
14	CTCF	chr21:45169729-45169858	GM12878	blood:	n/a	chr21:45169768-45169781
15	CTCF	chr21:45170788-45170800	GM19239	blood:	n/a	n/a
16	FOS	chr21:45169188-45169306	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr21:45169185-45169293	MCF10A-Er-Src	breast:	n/a	n/a
18	JUND	chr21:45169129-45169395	HepG2	liver:	n/a	chr21:45169264-45169275
19	JUND	chr21:45169104-45169395	Hela-S3	cervix:	n/a	chr21:45169264-45169275
20	JUND	chr21:45169282-45169295	H1-hESC	embryonic stem cell:	n/a	n/a
21	JUND	chr21:45169173-45169454	A549	lung:	n/a	chr21:45169264-45169275
22	MAX	chr21:45170687-45170929	NB4	blood:	n/a	chr21:45170730-45170740
23	MAX	chr21:45170681-45170874	K562	blood:	n/a	chr21:45170730-45170740
24	MAX	chr21:45170650-45170800	HepG2	liver:	n/a	chr21:45170730-45170740
25	MAX	chr21:45170596-45170875	K562	blood:	n/a	chr21:45170730-45170740
26	MYC	chr21:45170593-45170824	MCF-7	breast:	n/a	chr21:45170730-45170740
27	MYC	chr21:45170630-45170851	MCF-7	breast:	n/a	chr21:45170730-45170740
28	NFATC1	chr21:45170393-45171047	GM12878	blood:	n/a	n/a
29	NFATC1	chr21:45170338-45171049	GM12878	blood:	n/a	n/a
30	PBX3	chr21:45170446-45171013	GM12878	blood:	n/a	n/a
31	POLR2A	chr21:45171768-45172169	HepG2	liver:	n/a	n/a
32	POLR2A	chr21:45170324-45171501	HepG2	liver:	n/a	n/a
33	POLR2A	chr21:45172184-45172613	HL-60	blood:	n/a	n/a
34	POLR2A	chr21:45170623-45170934	HepG2	liver:	n/a	n/a
35	POLR2A	chr21:45171608-45171993	ECC-1	luminal epithelium:	n/a	n/a
36	POLR2A	chr21:45170553-45170902	GM12878	blood:	n/a	n/a
37	POLR2A	chr21:45168624-45168785	HepG2	liver:	n/a	n/a
38	POLR2A	chr21:45169325-45170233	K562	blood:	n/a	n/a
39	POLR2A	chr21:45169112-45169391	HepG2	liver:	n/a	n/a
40	POLR2A	chr21:45171607-45172475	Hela-S3	cervix:	n/a	n/a
41	POLR2A	chr21:45171789-45172540	A549	lung:	n/a	n/a
42	POLR2A	chr21:45170550-45170884	HepG2	liver:	n/a	n/a
43	POLR2A	chr21:45172253-45172301	K562	blood:	n/a	n/a
44	POLR2A	chr21:45172237-45173494	U87	brain:	n/a	n/a
45	POLR2A	chr21:45172569-45172579	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr21:45172523-45172538	K562	blood:	n/a	n/a
47	POLR2A	chr21:45172664-45172665	GM12878	blood:	n/a	n/a
48	POLR2A	chr21:45166910-45168967	A549	lung:	n/a	n/a
49	POLR2A	chr21:45169281-45169286	K562	blood:	n/a	n/a
50	POLR2A	chr21:45169578-45170835	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr21:45158524..45162841-chr21:45165683..45171048,8	K562	blood:
2	chr21:45164921..45166877-chr21:45166997..45169477,2	K562	blood:
3	chr21:45164290..45167394-chr21:45171722..45175273,3	K562	blood:
4	chr21:45167914..45170036-chr21:45175029..45177838,2	K562	blood:
5	chr21:45168554..45170321-chr21:45172450..45175239,2	MCF-7	breast:
6	chr21:45152139..45163298-chr21:45164540..45174522,16	K562	blood:
7	chr21:45165298..45166880-chr21:45168417..45169952,2	MCF-7	breast:
8	chr21:45161547..45167086-chr21:45167365..45170424,6	MCF-7	breast:
9	chr21:45170139..45171974-chr21:45180747..45184494,3	K562	blood:
10	chr21:45146930..45150669-chr21:45163613..45169103,5	K562	blood:
11	chr21:45163023..45165790-chr21:45170856..45174314,3	K562	blood:
12	chr21:45152139..45155102-chr21:45167592..45169327,2	K562	blood:
13	chr21:45154618..45156575-chr21:45170589..45173066,2	K562	blood:
14	chr21:33103919..33104588-chr21:45170107..45170783,2	Hela-S3	cervix:

Variant related genes	Relation type
PDXK	TF binding region
ENSG00000160209	chromatin interactions
ENSG00000156304	chromatin interactions

Extended variants
information (count: 258 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:258 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs539613535	chr21:45168632-45168633	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs565033056	chr21:45168633-45168634	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs532695008	chr21:45168669-45168670	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs113597750	chr21:45168709-45168710	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs569304807	chr21:45168717-45168718	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs561650513	chr21:45168731-45168732	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs183813749	chr21:45168732-45168733	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs548256703	chr21:45168774-45168775	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs187696739	chr21:45168777-45168778	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs534183554	chr21:45168795-45168796	Weak transcription Strong transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs557110935	chr21:45168832-45168833	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs369480555	chr21:45168836-45168837	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs552392400	chr21:45168837-45168838	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs374080979	chr21:45168871-45168872	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs377592729	chr21:45168879-45168880	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs11539534	chr21:45168884-45168885	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs112579284	chr21:45168914-45168915	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs61737062	chr21:45168923-45168924	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs370607729	chr21:45168969-45168970	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs573978630	chr21:45168976-45168977	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs9974827	chr21:45169005-45169006	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs536267138	chr21:45169015-45169016	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs192612266	chr21:45169037-45169038	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs573101989	chr21:45169093-45169094	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs540147520	chr21:45169110-45169111	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs371039433	chr21:45169130-45169131	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs142950288	chr21:45169142-45169143	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs9984121	chr21:45169147-45169148	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs530113150	chr21:45169169-45169170	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs559351287	chr21:45169174-45169175	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs4819307	chr21:45169175-45169176	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs140056797	chr21:45169177-45169178	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs186549492	chr21:45169184-45169185	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs570744468	chr21:45169220-45169221	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs375123629	chr21:45169227-45169228	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs150292949	chr21:45169231-45169232	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs549915363	chr21:45169256-45169257	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs555746718	chr21:45169374-45169375	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs192739689	chr21:45169426-45169427	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs535932266	chr21:45169436-45169437	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs184572746	chr21:45169462-45169463	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs572726917	chr21:45169492-45169493	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs563483912	chr21:45169577-45169578	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs534126475	chr21:45169616-45169617	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs9975602	chr21:45169634-45169635	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs577165866	chr21:45169658-45169659	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs544420832	chr21:45169669-45169670	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs530614316	chr21:45169693-45169694	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs34287411	chr21:45169709-45169710	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs574913827	chr21:45169731-45169732	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Neuroblastoma	20406844	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:228 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45149000-45194400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
2	chr21:45149400-45175400	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr21:45149800-45175200	Weak transcription	HUVEC	blood vessel
4	chr21:45149800-45188200	Weak transcription	Primary hematopoietic stem cells	blood
5	chr21:45150000-45173200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr21:45152200-45183400	Strong transcription	Monocytes-CD14+_RO01746	blood
7	chr21:45152400-45173200	Weak transcription	Psoas Muscle	Psoas
8	chr21:45154400-45184200	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
9	chr21:45154800-45174600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
10	chr21:45155200-45169200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
11	chr21:45156800-45170600	Strong transcription	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr21:45158200-45173800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
13	chr21:45160600-45185600	Strong transcription	Fetal Intestine Small	intestine
14	chr21:45160800-45187200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
15	chr21:45161000-45174400	Weak transcription	Fetal Heart	heart
16	chr21:45161200-45168800	Strong transcription	Primary hematopoietic stem cells short term culture	blood
17	chr21:45161200-45177200	Strong transcription	HepG2	liver
18	chr21:45161200-45183600	Strong transcription	Fetal Intestine Large	intestine
19	chr21:45161400-45176400	Strong transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr21:45161400-45182200	Strong transcription	Rectal Mucosa Donor 31	rectum
21	chr21:45161400-45183200	Strong transcription	Placenta Amnion	Placenta Amnion
22	chr21:45161400-45185400	Strong transcription	Primary neutrophils fromperipheralblood	blood
23	chr21:45161600-45170600	Strong transcription	Adipose Nuclei	Adipose
24	chr21:45161600-45171600	Strong transcription	Right Ventricle	heart
25	chr21:45161600-45172400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr21:45161600-45174600	Strong transcription	Primary monocytes fromperipheralblood	blood
27	chr21:45161600-45176800	Strong transcription	Placenta	Placenta
28	chr21:45161600-45177000	Strong transcription	Osteobl	bone
29	chr21:45161600-45178000	Strong transcription	Duodenum Mucosa	Duodenum
30	chr21:45161600-45179000	Strong transcription	Primary T helper cells fromperipheralblood	blood
31	chr21:45161600-45179400	Strong transcription	Primary T regulatory cells fromperipheralblood	blood
32	chr21:45161600-45183000	Strong transcription	Sigmoid Colon	Sigmoid Colon
33	chr21:45161800-45169400	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr21:45161800-45174400	Strong transcription	Spleen	Spleen
35	chr21:45161800-45184800	Strong transcription	Cortex derived primary cultured neurospheres	brain
36	chr21:45162000-45170400	Strong transcription	Gastric	stomach
37	chr21:45162000-45170400	Strong transcription	Pancreas	Pancrea
38	chr21:45162000-45176200	Strong transcription	Breast Myoepithelial Primary Cells	Breast
39	chr21:45162000-45177200	Strong transcription	Fetal Adrenal Gland	Adrenal Gland
40	chr21:45162000-45178000	Strong transcription	Lung	lung
41	chr21:45162000-45180000	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr21:45162000-45185200	Weak transcription	Thymus	Thymus
43	chr21:45162200-45181600	Strong transcription	NHEK	skin
44	chr21:45162400-45176600	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr21:45162400-45177000	Strong transcription	Fetal Stomach	stomach
46	chr21:45162400-45177600	Strong transcription	Colonic Mucosa	Colon
47	chr21:45162800-45174600	Strong transcription	Ovary	ovary
48	chr21:45163200-45170800	Strong transcription	Primary T helper 17 cells PMA-I stimulated	--
49	chr21:45163200-45176800	Strong transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
50	chr21:45163200-45183400	Strong transcription	NHLF	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links